Merck (MRK) Long-Term Debt Issuances (2010 - 2025)

Merck (MRK) has reported Long-Term Debt Issuances for 11 consecutive years, with $7.9 billion the latest figure, recorded in Q4 2025.

• On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $7.9 billion in Q4 2025; TTM through Dec 2025 was $13.9 billion, a 173587.5% increase from a year earlier, with the FY2025 full-year figure at $13.9 billion, up 285.66% from the prior year.
• Long-Term Debt Issuances was $7.9 billion for Q4 2025 at Merck, up from $6.0 billion in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $7.9 billion in Q4 2021 and troughed at -$7.0 million in Q3 2023.
• A 4-year average of $4.4 billion and a median of $6.0 billion in 2025 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances jumped 85.71% in 2024 and surged 596300.0% in 2025, its largest moves.
• Over 4 years, Long-Term Debt Issuances stood at $7.9 billion in 2021, then tumbled by 100.09% to -$7.0 million in 2023, then surged by 85.71% to -$1.0 million in 2024, then surged by 791900.0% to $7.9 billion in 2025.
• The last three Long-Term Debt Issuances figures came in at $7.9 billion (Q4 2025), $6.0 billion (Q3 2025), and -$1.0 million (Q3 2024), per Business Quant data.